The clinical significance of HER-2 and NF-κB expression in gastric cancer

Hepato-Gastroenterology

Volumn 60, Issue 126, 2013, Pages 1519-1523

  Li, Xiaogai ^a   Tu, Jiancheng ^a   Zhang, Di ^a   Xu, Zhigao ^a   Yang, Guifang ^a   Gong, Lingling ^a   Yu, Mingxia ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Enzyme linked immunosorbent assay; Gastric cancer; Human epidermal growth factor receptor; Immunohistochemical; NF B

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TISSUE DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NF-KAPPA B; RECEPTOR, ERBB-2; STOMACH NEOPLASMS;

EID: 84885803707     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13242     Document Type: Article

References (19)

1. Nicholson RI, Gee JM and Harper ME: EGFR and cancer prognosis. Eur J Cancer 2001; 37 Suppl 4:S9-15.
2. Gravalos C, Jimeno A: HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008; 19:1523-1529.
3. Hsu JT, Chen TC, Tseng JH, et al.; Impact of HER-2 overexpression/ amplifkation on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients. Oncologist 2011; 16:1706-1713.
4. Tse AK, Wan CK, Zhu GY, et al.: Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Molecular Immunol 2007; 44:2647-2658. (Pubitemid 46240318)
5. Ding Y, Huang X, Liu T, et al.: The Plasmodium circumsporozoite protein, a novel NF-kappaB inhibitor, suppresses the growth of SW480. Pathol Oncol Res 2012; 18:895-902.
6. Kwon HC, Kim SH, Oh SY, et al.: Clinicopathologic significance of expression of nuclear factor-kappaB RelA and its target gene products in gastric cancer patients. World J Gastroenterol 2012; 18:4744-4750.
7. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17:1474-1481. (Pubitemid 29220854)
8. Atmaca A, Werner D, Pauligk C, et al.: The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer. BMC Cancer 2012; 12:524.
9. Lee HE, Park KU, Yoo SB, et al.: Clinical significance of intratumoral HER2 heterogeneity in gastric cancer. Eur J Cancer 2013; 49(6):1448-1457.
10. Huang C, Huang K, Wang C, et al.: Overexpression of mitogenactivated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Oncol Reports 2009; 22:89-95.
11. Okines AF and Cunningham D: Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer. Therapeu Adv Gastroenterol 2012; 5:301-318.
12. Li Y, Wang Y, Zhang X, et al.: HER2 gene status and the relationship with p21 protein expression in gastric cancer. Chinese-German J Clin Oncol 2011; 10:162-165.
13. Raziee HR, Kermani AT, Ghaffarzadegan K, et al.: HER-2/neu Expression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage. Iranian J Basic Med Sci 2007; 10:139-145.
14. Wei J, Noto J, Zaika E, et al.: Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. PNAS USA 2012; 109:E2543-2550.
15. Matsumoto Y, Marusawa H, Kinoshita K, et al.: Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nature Med 2007; 13:470-476. (Pubitemid 46559833)
16. Pikarsky E, Porat RM, Stein I, et al.: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431:461-466. (Pubitemid 39329586)
17. Aggarwal BB, Shishodia S, Sandur SK, et al.: Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006; 72:1605-1621. (Pubitemid 44666739)
18. Le Page C, Koumakpayi IH, Lessard L, et al.: EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells. Prostate 2005; 65:130-140. (Pubitemid 41362280)
19. Hinohara K, Kobayashi S, Kanauchi H, et al.: ErbB receptor tyrosine kinase/NF-kappaB signaling controls mammosphere formation in human breast cancer. PNAS USA 2012; 109:6584-6589